The cerebrospinal fluid (CSF) biomarkers used for AD diagnosis are the 42-amino acid Aβ peptide (Aβ1-42) and the tau protein in its total composition and as phosphorylated residue at threonine 181 (T-tau and P-tau, respectively). This evidence concerns the gene MAPT and Alzheimer disease.